Evidence map›Paper›PMID 42129224›Full record

ArticleNPJ science of food2026

3D bio-screen printing for high-throughput production of scaffolds for meat alternatives.

Robin Maatz, Philipp Karnop, Ryan Sylvia, Thomas Herget, Andreas Blaeser

Erratum issuedAbstract read
In one paragraph

Article in NPJ science of food, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Robin MaatzInstitute for BioMedical Printing Technology, TU Darmstadt, Darmstadt, Germany. maatz@idd.tu-darmstadt.de.
Philipp KarnopInstitute for BioMedical Printing Technology, TU Darmstadt, Darmstadt, Germany.
Ryan SylviaMerck KGaA, Darmstadt, Germany.
Thomas HergetInstitute for BioMedical Printing Technology, TU Darmstadt, Darmstadt, Germany.
Andreas BlaeserInstitute for BioMedical Printing Technology, TU Darmstadt, Darmstadt, Germany. blaeser@idd.tu-darmstadt.de.ORCID http://orcid.org/0000-0003-3459-4268

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing the production of structured cultivated meat (CM) remains a major challenge. Many current 3D printing and bioprinting technologies lack the necessary throughput, material compatibility, and cytocompatibility to produce realistic meat alternatives. In this study, screen printing, a traditional high-throughput printing technology, was investigated for the first time for the application of meat alternatives. The new process, 3D bio-screen printing (3D-BSP), presents a biomanufacturing process that uses edible materials (e.g., plant proteins) to produce meat-like structures with high resolution (0.1 mm). The suitability of edible inks for the 3D-BSP process was investigated on the basis of soy protein isolate (SPI) rheologically (flow index value < 0.4) and in terms of printability. In order to increase the protein content in edible inks while maintaining processability, an approach based on reducing agents was investigated. Sodium sulphite served as a demonstration model and resulted in a high protein content (>20 wt%) in SPI, while maintaining the flow properties suitable for processing protein-rich inks. To test the suitability as scaffolding technology for hybrid cultivated meat, meat-like scaffold structures were printed with C2C12 myoblasts differentiated on them. The printability of the structures was high in the resolution range investigated from 0.1 mm to 1 mm and supported 2D and 3D myoblast cultures (64% actin coverage and myotube formation). Ultimately, a marbled prototype was produced whose thickness could be increased by a stacking approach (>0.5cm). The texture profile (e.g., chewiness) of stacked and printed scaffolds was comparable to that of conventional meat. Upon successful transfer of the process parameters determined here to industrial screen printing machines, production rates of >100 kg/h could be achieved with one machine in the future. 3D-BSP offers a practical and cost-effective perspective for the mass production of structured meat in industrial quantities using screen printing technology. It could remove technical and economic barriers in this area and bring us closer to the commercial production of high-quality meat alternatives.

Identifiers

PMID42129224
PMCPMC13172316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.